4
Changes in Ownership
NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-012654
CHIEF EXECUTIVE OFFICER bought 50,000 shares at $1.17 ($58,500)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Willard Stephen H CHIEF EXECUTIVE OFFICER | 2022-12-16 | Purchase | +50,000 | $1.17 | $58,500 | 50,000 | D: show line 1 in the form |
| Open-market purchases · 50,000 sh · avg $1.17 · $58,500 | |||||||
Loading xslF345X03/form4-12192022_121215.xml…